Multiple endogenous growth factor pathways via scaffold-mediated release

Multiple endogenous growth factor pathways via scaffold-mediated release refers to a therapeutic strategy in regenerative medicine rather than a single molecular target. This approach utilizes bioengineered scaffolds—such as collagen matrices, synthetic hydrogels, or decellularized tissues—to deliver and control the release of various growth factors (e.g., VEGF, BMP, PDGF) to a site of injury (Source: PubMed PMC3534913). By mimicking the natural extracellular matrix, these scaffolds facilitate the activation of multiple signaling cascades in resident cells, promoting complex biological processes like angiogenesis, osteogenesis, and wound healing (Source: NIH/NCBI). While highly effective for tissue engineering, the complexity of coordinating multiple pathways simultaneously presents challenges in controlling the spatial and temporal release of these potent biological signals (Source: Journal of Controlled Release). Clinical applications include the treatment of chronic diabetic foot ulcers and complex surgical wounds where natural healing is impaired (Source: PubMed 23038467).

Other names

Growth factor delivery systemsBioactive scaffoldsRegenerative signaling pathwaysControlled release growth factor therapy

The mechanism involves the use of a biocompatible scaffold to deliver and slowly release multiple growth factors, which then activate endogenous signaling pathways (e.g., MAPK, PI3K/Akt) via their respective receptors to promote tissue repair (Source: PubMed PMC3534913).